Stock Analysis:Unitedhealth Group Inc (NYSE:UNH) Target Increased
In an analyst research report issued to investors and clients by BMO Capital Markets on Wednesday, 2 December, Unitedhealth Group Inc (NYSE:UNH) had its TP increased to $138.00. The firm at present has a solid Outperform rating on shares.
From a total of 22 analysts covering UnitedHealth Group (NYSE:UNH) stock, 20 rate it a ”Buy”, 0 a “Sell”, and 3 a ”Hold”. This means that 87% of the ratings are positive. The highest target price is $172 while the lowest target price is $130. The mean of all analyst targets is $142.18 with a 16.20% above today’s ($117.78) stock price. UnitedHealth Group was the topic of 11 analyst reports since September 2, 2015 according to the firm StockzIntelligence Inc. Mizuho maintained shares on November 20 with “Buy” rating. Citigroup initiated UNH stock in a recent report from October 2 with “Buy” rating. Finally, Vetr upgraded the stock to “Strong-Buy” rating in a report issued on a September 2.
Approximately 444,149 shares of stock traded hands. UnitedHealth Group Inc (NYSE:UNH) has risen 2.33% since April 29, 2015 and is uptrending. It has outperformed by 2.53% the S&P500.
UnitedHealth Group Incorporated is a health and well-being company. The company has a market cap of $112.16 billion. The Company’s business platforms include UnitedHealthcare and Optum. It has 18.87 P/E ratio. UnitedHealthcare provides health care benefits to various clients and markets.
According to Zacks Investment Research, “UnitedHealth Group Inc. offers health care coverage and related services to help people achieve improved health and well-being through all stages of life. The company’s products and services reflect a number of core capabilities, including medical information management, health benefit administration, care coordination, risk assessment and pricing, health benefit design and provider contracting. With these capabilities, it is able to provide comprehensive health care management services through organized health systems and insurance products.” Get a free copy of the Zacks research report on UnitedHealth Group Inc (UNH).